ArticleCureus2025
Complex Clinical Interplay: A Case Report of Systemic Lupus Erythematosus Coexisting With Type II Cryoglobulinemia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An observational study on lupus nephritis combined with cryoglobulinemia.Renal failure · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is a multi-faceted autoimmune disease with diverse clinical manifestations, often diagnosed through specific immunological markers. Another noteworthy immunological phenomenon associated with SLE is cryoglobulinemia (CG), characterized by circulating immunoglobulins that precipitate at lower temperatures. Although the overlap of SLE and CG is documented, its precise prevalence remains elusive. This paper presents a unique case of a patient diagnosed with lupus cryoglobulinemic glomerulonephritis through biopsy. The patient attained full remission after an initial induction using the Eurolupus protocol complemented with plasmapheresis, with subsequent maintenance therapy managed via rituximab.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.